Cargando…
Effectiveness of Nitazoxanide and Electrolyzed Oxiding Water in Treating Chagas Disease in a Canine Model
Chagas disease (CD) is caused by the protozoan Trypanosoma cruzi, and affects seven million people in Latin America. Side effects and the limited efficacy of current treatment have led to new drug research. The objective of this work was to evaluate the effectiveness of nitazoxanide (NTZ) and electr...
Autores principales: | Rodríguez-Morales, Olivia, Mendoza-Téllez, Erika Jocelin, Morales-Salinas, Elizabeth, Arce-Fonseca, Minerva |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10224175/ https://www.ncbi.nlm.nih.gov/pubmed/37242721 http://dx.doi.org/10.3390/pharmaceutics15051479 |
Ejemplares similares
-
Nitazoxanide: A Drug Repositioning Compound with Potential Use in Chagas Disease in a Murine Model
por: Arce-Fonseca, Minerva, et al.
Publicado: (2023) -
Echocardiographic Findings in Canine Model of Chagas Disease Immunized with DNA Trypanosoma cruzi Genes
por: Rodríguez-Morales, Olivia, et al.
Publicado: (2020) -
Electrolyzed Oxidizing Water Modulates the Immune Response in BALB/c Mice Experimentally Infected with Trypanosoma cruzi
por: Rodríguez-Morales, Olivia, et al.
Publicado: (2020) -
Prophylactic and therapeutic DNA vaccines against Chagas disease
por: Arce-Fonseca, Minerva, et al.
Publicado: (2015) -
Plasmid DNA immunization with Trypanosoma cruzi genes induces cardiac and clinical protection against Chagas disease in the canine model
por: Rodríguez-Morales, Olivia, et al.
Publicado: (2012)